Searching map area
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
? TBD
scientific article published on July 16, 2012
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Lists 0
Join to rate
Reading
Full Texteuropepmc.org
Elsewhere
Originaleuropepmc.org
Instance of
Scholarly article
Author
Razelle Kurzrock
Keith Flaherty
Jeffrey R Infante
Vijay G R Peddareddigari
Leslie A Fecher
Douglas J DeMarini
Howard A Burris
Ngocdiep T Le
Nicholas J. Vogelzang
Gerald Falchook
Wells A Messersmith
Johanna Bendell
Subject
First-in-man study
Patient
References
Wikidata